Your browser is no longer supported. Please, upgrade your browser.
Settings
BCR CR Bard Inc. daily Stock Chart
BCR [NYSE]
CR Bard Inc.
IndexS&P 500 P/E47.06 EPS (ttm)3.64 Insider Own0.60% Shs Outstand74.25M Perf Week-0.90%
Market Cap12.72B Forward P/E17.22 EPS next Y9.95 Insider Trans-29.23% Shs Float73.84M Perf Month-0.19%
Income279.40M PEG4.36 EPS next Q2.18 Inst Own90.50% Short Float2.48% Perf Quarter2.14%
Sales3.34B P/S3.80 EPS this Y-55.20% Inst Trans-0.72% Short Ratio3.84 Perf Half Y3.07%
Book/sh23.51 P/B7.29 EPS next Y10.31% ROA5.50% Target Price184.38 Perf Year17.85%
Cash/sh13.52 P/C12.67 EPS next 5Y10.79% ROE15.80% 52W Range140.93 - 180.94 Perf YTD3.07%
Dividend0.96 P/FCF28.47 EPS past 5Y-4.00% ROI10.10% 52W High-5.33% Beta0.70
Dividend %0.56% Quick Ratio1.80 Sales past 5Y5.60% Gross Margin62.30% 52W Low21.55% ATR2.35
Employees13900 Current Ratio2.30 Sales Q/Q2.60% Oper. Margin24.80% RSI (14)50.50 Volatility1.37% 1.29%
OptionableYes Debt/Eq0.93 EPS Q/Q-2.20% Profit Margin8.40% Rel Volume0.71 Prev Close172.77
ShortableYes LT Debt/Eq0.66 EarningsJul 23 AMC Payout23.30% Avg Volume475.83K Price171.30
Recom2.70 SMA200.01% SMA500.12% SMA2002.92% Volume339,293 Change-0.85%
Apr-24-15Reiterated Barclays Equal Weight $175 → $185
Jan-30-15Reiterated Barclays Equal Weight $150 → $175
Jun-18-14Downgrade Barclays Overweight → Equal Weight $155 → $150
Mar-06-14Reiterated Barclays Overweight $150 → $160
Jan-09-14Reiterated Barclays Overweight $140 → $150
Oct-23-13Reiterated Barclays Overweight $135 → $140
Sep-04-13Initiated Needham Hold
Jul-24-13Reiterated Barclays Overweight $112 → $125
Jun-04-13Reiterated Deutsche Bank Hold $98 → $106
Mar-08-13Reiterated Northland Capital Market Perform $105 → $111
Feb-01-13Reiterated Barclays Overweight $117 → $112
Feb-01-13Initiated Mizuho Neutral $88 → $94
Jan-04-13Reiterated Deutsche Bank Hold $93 → $97
Nov-20-12Initiated Stifel Nicolaus Hold
Oct-24-12Reiterated Mizuho Neutral $93 → $88
Sep-24-12Upgrade Barclays Underweight → Overweight $101 → $117
Apr-25-12Reiterated Mizuho Neutral $86 → $93
Feb-23-12Initiated Northland Securities Market Perform $105
Sep-23-11Reiterated Barclays Capital Underweight $82 → $87
Sep-16-11Initiated Rodman & Renshaw Mkt Perform
Jul-01-15 12:00PM  Bard to Host Earnings Conference Call on July 23, 2015 Business Wire
Jun-26-15 02:40PM  CR Bard's Lutonix DCB Proves Effective in LEVANT 2 Study - Analyst Blog
Jun-25-15 07:30AM  The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix┬« Drug Coated Balloon, showing superior efficacy compared to standard PTA Business Wire
Jun-24-15 02:10PM  Covidien agrees to settle some cases over transvaginal mesh devices
02:10PM  Henry Schein's Buyout Plan Eyes Nordic Animal Health Market - Analyst Blog
Jun-18-15 01:37PM  BARD C R INC /NJ/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jun-16-15 02:13PM  Edited Transcript of BCR presentation 12-May-15 11:20pm GMT
Jun-10-15 04:06PM  Bard Announces $500 Million Share Repurchase Authorization Business Wire
04:05PM  Bard Increases Quarterly Dividend Business Wire
02:10PM  C. R. Bard's Lutonix DCB Gets Full Reimbursement Approval - Analyst Blog
Jun-09-15 11:50AM  CMS Further Improves Reimbursement for Lutonix DCB for Outpatient Use Business Wire
May-27-15 12:57PM  Top trades for the 2nd half: COST, LPL, SCHW & NVDA
May-26-15 10:45AM  Bard to Present at Jefferies Healthcare Conference Business Wire
May-06-15 06:04AM  BARD C R INC /NJ/ Files SEC form 8-K, Other Events
May-05-15 11:22AM  Bard to Present at the Bank of America Merrill Lynch Healthcare Conference at noodls
10:30AM  Bard to Present at the Bank of America Merrill Lynch Healthcare Conference Business Wire
Apr-30-15 01:04PM  BARD C R INC /NJ/ Financials
Apr-28-15 12:35PM  Boston Scientific reaches first transvaginal mesh settlement Reuters
12:07PM  Boston Scientific (BSX) Earnings Report: Q1 2015 Conference Call Transcript at TheStreet
Apr-24-15 01:46PM  BARD C R INC /NJ/ Files SEC form 10-Q, Quarterly Report
09:48AM  C.R. Bard (BCR) Q1 Earnings, Sales Top; Currency Woes Stay - Analyst Blog
09:02AM  CR Bard (BCR) Earnings Report: Q1 2015 Conference Call Transcript at TheStreet
Apr-23-15 05:00PM  C R Bard Inc Earnings Call scheduled for 5:00 pm ET today
04:26PM  Bard Announces First Quarter Results at noodls
04:20PM  BARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
04:05PM  Bard Announces First Quarter Results Business Wire
07:07AM  Q1 2015 C R Bard Inc Earnings Release - After Market Close
Apr-22-15 05:04PM  Medical Equipment Stocks Are Ready to Break Out at Barrons.com
Apr-21-15 05:20PM  C. R. Bard (BCR) Q1 Earnings: Lutonix DCB Holds the Key - Analyst Blog
Apr-17-15 02:46PM  3 Stocks Breaking Out on Unusual Volume at TheStreet
06:03AM  BARD C R INC /NJ/ Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of S
Apr-15-15 04:29PM  Bard Declares Quarterly Dividend at noodls
04:05PM  Bard Declares Quarterly Dividend Business Wire
Apr-09-15 08:32AM  BARD C R INC /NJ/ Files SEC form 8-K, Other Events
Apr-01-15 03:36PM  Bard to Host Earnings Conference Call on April 23, 2015 at noodls
03:30PM  Bard to Host Earnings Conference Call on April 23, 2015 Business Wire
Mar-13-15 06:21PM  CryoLife, CR Bard War over Patent Infringement Continues - Analyst Blog
Mar-04-15 12:14PM  Bard to Present at Barclays Global Healthcare Conference at noodls
12:00PM  Bard to Present at Barclays Global Healthcare Conference Business Wire
Mar-03-15 12:12PM  CMS Approves Pass-Through Payment for Lutonix DCB for Outpatient Use at noodls
Feb-25-15 11:10AM  Bard to Present at Raymond James Institutional Investors Conference at noodls
10:30AM  Bard to Present at Raymond James Institutional Investors Conference Business Wire
Feb-24-15 04:49PM  Reversing a Declining Pattern in Earnings Per Share
Feb-23-15 06:14PM  CR Bard's Lutonix DCB Gets Pass-Through Payment Approval - Analyst Blog
Feb-19-15 11:52AM  CMS Approves Pass-Through Payment for Lutonix DCB for Outpatient Use Business Wire
Feb-18-15 02:12PM  BARD C R INC /NJ/ Files SEC form 10-K, Annual Report EDGAR Online
10:03AM  CryoLife (CRY) Down as Q4 Earnings Fall; Revenues Rise Y/Y - Analyst Blog Zacks
Feb-13-15 02:06PM  C.R. Bard, Inc. -- Moody's downgrades C.R. Bard's long term rating to Baa1 from A3; outlook stable at Moody's
Feb-11-15 07:54AM  JMP Securities Covers Mostly Good News From Pharma Pending More Visibility Benzinga
Feb-10-15 05:40PM  CR Bard, Boston Scientific Ink Lutonix Distribution Agreement - Analyst Blog Zacks
Feb-09-15 09:00AM  Boston Scientific And C. R. Bard Announce Distribution Agreement For Lutonix┬« Drug Coated Balloon PR Newswire
Feb-03-15 07:28PM  Lightning Round: Chicken is now a commodity at CNBC
Jan-30-15 05:51PM  Friday's Market Recap Yahoo Finance Contributors
03:00PM  C.R. Bard Beats Q4 Earnings and Sales, 15' Outlook Cautious - Analyst Blog Zacks
Jan-29-15 05:00PM  C R Bard Inc Earnings Call scheduled for 5:00 pm ET today CCBN
04:12PM  BARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit EDGAR Online
04:05PM  Bard Announces Fourth Quarter Results Business Wire
07:07AM  Q4 2014 C R Bard Inc Earnings Release - After Market Close CCBN
Jan-28-15 03:30PM  Zimmer (ZMH) Likely to Miss Estimates this Earnings Season - Analyst Blog Zacks
01:40PM  Is Thermo Fisher (TMO) Poised to Surprise Q4 Earnings? - Analyst Blog Zacks
Jan-27-15 02:40PM  Will Mead Johnson (MJN) Disappoint Q4 Earnings Estimates? - Analyst Blog Zacks
10:30AM  Can CR Bard (BCR) Keep the Earnings Streak Alive in Q4? - Analyst Blog Zacks
Jan-26-15 12:10PM  CareFusion Banks on Pipeline Strength, Pricing Woes Remain - Analyst Blog Zacks
Jan-23-15 02:00PM  Can Illumina (ILMN) Keep the Earnings Streak Alive in Q4? - Analyst Blog Zacks
Jan-20-15 02:30PM  Henry Schein to Expand in Animal Health with scil Acquisition - Analyst Blog Zacks
Jan-15-15 06:20PM  Teleflex Collaborates with HealthTrust for ARROW Devices - Analyst Blog Zacks
06:05PM  Henry Schein Expands Dental Practice Transition in Florida - Analyst Blog Zacks
Jan-13-15 05:00PM  BARD C R INC /NJ/ Files SEC form 8-K, Other Events EDGAR Online
Jan-12-15 05:29PM  And Oil continues to fall... Yahoo Finance Contributors
Jan-06-15 12:00PM  Bard to Host Earnings Conference Call on January 29, 2015 Business Wire
11:00AM  Bard to Present at J.P. Morgan Healthcare Conference Business Wire
08:02AM  Top-Performing Core Funds Make Up Some Ground at Investor's Business Daily
Jan-05-15 03:57PM  Morgan Stanley Issues Wave Of Pharma & Medical Device Upgrades, Downgrades Benzinga
Dec-29-14 12:48PM  [$$] St. Jude's Six-Week Surge About to Start at Barrons.com
Dec-12-14 12:01AM  Bard Judge Says Implant Maker Facing Billions in Verdicts at Bloomberg
Dec-10-14 07:55PM  Top Performing Funds: Core Style Straddles The Line at Investor's Business Daily
04:05PM  Bard Declares Quarterly Dividend Business Wire
10:04AM  12 'financial potholes' to avoid now at USA TODAY
Dec-05-14 03:09PM  The Cooper Companies Q4 Earnings, Revenues Lag; Up Y/Y Zacks
Dec-03-14 07:55PM  Top Performing Funds: Core Style Straddles The Line at Investor's Business Daily
04:50PM  Teleflex Partners with Premier to Expand Dialysis Portfolio Zacks
Nov-25-14 05:55PM  Henry Schein, Cardinal Health Sign Physician Service Deal Zacks
Nov-21-14 03:27PM  BARD C R INC /NJ/ Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance EDGAR Online
Nov-20-14 03:39PM  Invacare (IVC) Down to Strong Sell on Dismal Q3 Results Zacks
03:38PM  Henry Schein Strong on Healthy Track Record, Fundamentals Zacks
Nov-19-14 02:30PM  Bard to Present at the Piper Jaffray Healthcare Conference Business Wire
12:10PM  CR Bard (BCR) Scales 52-Week High on Strong Q3 Results Zacks
Nov-17-14 05:10PM  Covidien's Test Data Positive for VenaSeal Closure System Zacks
03:34PM  LabCorp Shows Strength on Covance Buyout Plan, Robust Q3 Zacks
04:33AM  Cramer: Stocks That Stand Out TheStreet
Nov-13-14 04:17PM  Miami jury begins deliberations in Boston Scientific mesh trial Reuters
Nov-12-14 09:00AM  MWI Veterinary Beats Q4 Earnings & Sales yet Shares Fall Zacks
Nov-11-14 01:50PM  Boston Scientific Shows Strength on Core Market Stabilization Zacks
10:30AM  Henry Schein Tops Q3 Earnings, Revenues; Shares Rally Zacks
09:10AM  Steris Gains on Q2 Earnings and Revenue Beat; EPS View Up Zacks
Nov-07-14 08:30AM  CareFusion Q1 Earnings, Revenues Rise and Beat Estimates Zacks
Nov-05-14 01:00PM  Bard to Present at the Stifel Healthcare Conference Business Wire
Nov-04-14 05:07PM  Covidien to Sell Stellarex DCB to Spectranetics for $30M Zacks
Nov-03-14 09:03AM  RPT-Halyard Health poised to shine in debut on back of Ebola scare Reuters
Oct-28-14 09:46AM  Today CR Bard (BCR) Hits New Lifetime High at TheStreet
C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. The company offers vascular products, such as percutaneous transluminal angioplasty catheters, chronic total occlusion catheters, guidewires, fabrics, meshes, introducers, and accessories; valvuloplasty balloons; peripheral vascular stents, self-expanding and balloon-expandable covered stents, and vascular grafts; vena cava filters; biopsy devices; and temporary pacing electrode catheters for the treatment of peripheral vascular disease and heart arrhythmias. It also provides urology products, including Foley catheters to reduce the rate of urinary tract infections; fecal incontinence products; brachytherapy devices and radioactive seeds for the treatment of prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for stone removal procedures; surgical slings and pelvic floor repair products; catheter stabilization devices; and products for therapeutic hypothermia. In addition, the company offers oncology products that include specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters, and enteral feeding devices to treat and manage various cancers, and other diseases and disorders. Further, it provides surgical specialty products comprising implanted grafts and fixation devices for hernia and soft tissue repairs; and hemostats and surgical sealants, as well as other products, such as irrigation, wound drainage, and original equipment manufacturers' products. The company sells its products directly to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. C. R. Bard, Inc. was founded in 1907 and is headquartered in Murray Hill, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thompson Tommy GDirectorApr 28Option Exercise63.431,20076,1169,519Apr 29 05:36 PM
Naughton Gail KDirectorApr 28Sale170.61763130,1782,008Apr 29 05:36 PM
Thompson Tommy GDirectorApr 28Sale170.431,200204,5158,319Apr 29 05:36 PM
RING TIMOTHY MChairman and CEOMar 23Option Exercise83.477,628636,732129,083Mar 25 09:38 AM
RING TIMOTHY MChairman and CEOMar 23Sale170.657,6281,301,687121,455Mar 25 09:38 AM
BRESLAWSKY MARC CDirectorFeb 24Option Exercise76.367,200549,76619,319Feb 26 06:13 PM
BRESLAWSKY MARC CDirectorFeb 24Sale174.377,2001,255,49312,119Feb 26 06:13 PM
RING TIMOTHY MChairman and CEOFeb 23Option Exercise83.4720,0001,669,460141,455Feb 25 07:28 PM
RING TIMOTHY MChairman and CEOFeb 23Sale176.3320,0003,526,583121,455Feb 25 07:28 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOFeb 20Option Exercise96.5111,4401,104,05837,111Feb 24 07:08 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOFeb 20Sale176.0316,0912,832,52321,020Feb 24 07:08 PM
DeFord John ASr. VP Sci Tech and Clin AfrsFeb 20Sale174.852,987522,26423,646Feb 24 07:08 PM
Luboff Sharon MGroup Vice PresidentFeb 19Sale174.421,117194,83031,149Feb 20 03:51 PM
WEILAND JOHN HPresident and COOFeb 19Sale174.998,4131,472,21179,409Feb 20 03:51 PM
Beasley Jim CGroup PresidentFeb 19Sale174.792,884504,10424,313Feb 20 03:51 PM
Groetelaars John PGroup Vice PresidentFeb 19Sale175.144,566799,70520,103Feb 20 03:51 PM
RING TIMOTHY MChairman and CEOFeb 18Sale175.454,531794,980121,455Feb 20 03:51 PM
Collins Timothy PGroup PresidentFeb 18Sale175.554,583804,53831,512Feb 20 03:51 PM
Christian Patricia GVP -Quality, Reg & Med AffairsFeb 18Sale175.561,213212,95612,679Feb 20 03:51 PM
HENKEL HERBERT LDirectorFeb 17Option Exercise76.367,200549,76617,561Feb 19 05:29 PM
HENKEL HERBERT LDirectorFeb 17Sale174.607,2001,257,12810,361Feb 19 05:29 PM
WEILAND JOHN HPresident and COOFeb 17Sale174.5113,6162,376,18087,822Feb 18 05:48 PM
DeFord John ASr. VP Sci Tech and Clin AfrsFeb 17Sale174.586,1461,072,95126,633Feb 18 05:48 PM
Beasley Jim CGroup PresidentFeb 17Sale174.589,9041,729,00627,197Feb 18 05:48 PM
Luboff Sharon MGroup Vice PresidentFeb 17Sale174.578,7721,531,29732,266Feb 18 05:48 PM
Collins Timothy PGroup PresidentFeb 17Sale174.572,210385,79540,253Feb 18 05:48 PM
RING TIMOTHY MChairman and CEOFeb 17Sale175.182,453429,721130,097Feb 18 05:48 PM
RING TIMOTHY MChairman and CEOFeb 13Sale174.473,831668,387132,550Feb 18 05:48 PM
WHITE TONY LDirectorFeb 12Option Exercise65.112,400156,27015,268Feb 17 02:18 PM
RING TIMOTHY MChairman and CEOFeb 12Sale173.7414,3632,495,434138,758Feb 13 08:08 PM
Collins Timothy PGroup PresidentFeb 12Sale174.006,5641,142,15043,408Feb 13 08:08 PM
Christian Patricia GVP -Quality, Reg & Med AffairsFeb 12Sale173.971,408244,95214,489Feb 13 08:08 PM
WHITE TONY LDirectorFeb 12Sale174.172,400418,01412,868Feb 17 02:18 PM
WELTERS ANTHONYDirectorFeb 09Sale169.021,563264,1771,956Feb 11 03:28 PM
Luboff Sharon MGroup Vice PresidentFeb 03Sale170.2139667,40329,218Feb 05 03:31 PM
RING TIMOTHY MChairman and CEOJan 22Option Exercise83.4720,0001,669,460141,448Jan 23 05:31 PM
RING TIMOTHY MChairman and CEOJan 22Sale177.8420,0003,556,780121,448Jan 23 05:31 PM
RING TIMOTHY MChairman and CEODec 22Option Exercise79.8632,3252,581,387153,773Dec 23 12:47 PM
RING TIMOTHY MChairman and CEODec 22Sale169.6432,3255,483,533121,448Dec 23 12:47 PM
Beasley Jim CGroup PresidentDec 17Sale168.424,525762,09923,100Dec 18 04:17 PM
Luboff Sharon MGroup Vice PresidentDec 17Sale168.363,564600,04129,738Dec 18 04:17 PM
Christian Patricia GVP -Quality, Reg & Med AffairsDec 17Sale168.0232855,11212,196Dec 18 04:17 PM
Collins Timothy PGroup PresidentDec 17Sale168.413,960666,91733,261Dec 18 04:17 PM
DeFord John ASr. VP Sci Tech and Clin AfrsDec 16Option Exercise84.585,626475,81930,498Dec 17 06:15 PM
Beasley Jim CGroup PresidentDec 16Option Exercise89.9314,6341,316,04242,259Dec 17 06:15 PM
Beasley Jim CGroup PresidentDec 16Sale167.4714,6342,450,73927,625Dec 17 06:15 PM
DeFord John ASr. VP Sci Tech and Clin AfrsDec 16Sale167.475,626942,19224,872Dec 17 06:15 PM
RING TIMOTHY MChairman and CEODec 16Sale166.6015,2322,537,668121,448Dec 17 06:15 PM
WEILAND JOHN HPresident and COODec 16Sale167.019,5041,587,23383,486Dec 17 06:15 PM
WEILAND JOHN HPresident and COODec 15Option Exercise84.5813,5891,149,290115,785Dec 17 06:15 PM
WEILAND JOHN HPresident and COODec 15Sale166.5613,5892,263,342102,196Dec 17 06:15 PM
Christian Patricia GVP -Quality, Reg & Med AffairsDec 12Sale168.3016026,92812,708Dec 16 03:59 PM
Christian Patricia GVP -Quality, Reg & Med AffairsDec 10Sale169.201,269214,71413,161Dec 12 05:37 PM
RING TIMOTHY MChairman and CEODec 09Sale170.209,5501,625,373151,433Dec 10 04:07 PM
WEILAND JOHN HPresident and COODec 09Sale170.326,3501,081,508102,196Dec 10 04:07 PM
RING TIMOTHY MChairman and CEONov 21Option Exercise77.1560,0004,629,060230,233Nov 25 05:16 PM
RING TIMOTHY MChairman and CEONov 21Sale166.7560,00010,005,125170,233Nov 25 05:16 PM
Lupisella Frank JrVice President and ControllerOct 30Option Exercise85.695,980512,42924,161Nov 03 05:03 PM
Lupisella Frank JrVice President and ControllerOct 30Sale160.205,980957,99618,181Nov 03 05:03 PM
RING TIMOTHY MChairman and CEOOct 22Option Exercise77.1560,0004,629,060230,233Oct 24 04:08 PM
RING TIMOTHY MChairman and CEOOct 22Sale149.0760,0008,944,243170,233Oct 24 04:08 PM
RING TIMOTHY MChairman and CEOOct 06Option Exercise77.1560,0004,629,060230,233Oct 08 04:55 PM
RING TIMOTHY MChairman and CEOOct 06Sale148.0060,0008,880,000170,233Oct 08 04:55 PM
WEILAND JOHN HPresident and COOSep 10Option Exercise84.5827,1792,298,664141,875Sep 11 04:22 PM
WEILAND JOHN HPresident and COOSep 10Sale149.5027,1794,063,261114,696Sep 11 04:22 PM
RING TIMOTHY MChairman and CEOSep 02Option Exercise66.8010,228683,179180,461Sep 04 02:13 PM
RING TIMOTHY MChairman and CEOSep 02Sale148.8310,2281,522,188170,233Sep 04 02:13 PM
KELLY BRONWEN KVP - Human ResourcesAug 04Option Exercise83.4710,055839,32131,910Aug 06 03:34 PM
KELLY BRONWEN KVP - Human ResourcesAug 04Sale150.2510,0551,510,73721,855Aug 06 03:34 PM
RING TIMOTHY MChairman and CEOAug 01Option Exercise66.8010,231683,380180,464Aug 05 05:11 PM
RING TIMOTHY MChairman and CEOAug 01Sale149.0410,2311,524,808170,233Aug 05 05:11 PM
Melcher David FDirectorJul 31Buy150.4950075,243500Aug 01 03:33 PM
Collins Timothy PGroup PresidentJul 30Option Exercise86.1529,9402,579,18171,971Aug 01 03:33 PM
Collins Timothy PGroup PresidentJul 30Sale150.3830,9144,648,88841,057Aug 01 03:33 PM
Christian Patricia GVP -Quality, Reg & Med AffairsJul 29Option Exercise85.7312,7011,088,86327,498Jul 31 05:23 PM
Luboff Sharon MGroup Vice PresidentJul 29Option Exercise88.765,115453,98242,251Jul 31 05:23 PM
Luboff Sharon MGroup Vice PresidentJul 29Sale151.375,115774,23637,136Jul 31 05:23 PM
Christian Patricia GVP -Quality, Reg & Med AffairsJul 29Sale151.3412,7011,922,21614,797Jul 31 05:23 PM